TABLE 3

Initial bronchial artery embolisation (BAE) strategy versus non-BAE strategy

Initial BAE strategyInitial non-BAE strategy#
Patients87 (52.7%)78 (47.3%)
Age years mean64.261.1
Female sex31 (35.6%)35 (44.9%)
Volume of haemoptysis mL per 24 h mean206.8163.3
Severe haemoptysis47 (54.0%)26 (33.3%)
Length of hospital stay days mean9.68.6
ICU40 (46.0%)22 (28.2%)
Endotracheal intubation15 (17.2%)9 (11.5%)
In-hospital mortality10 (11.5%)14 (17.9%)
Aetiologies
 Lung cancer27 (31.0%)23 (29.5%)
 Bronchiectasis17 (19.5%)18 (23.1%)
 Idiopathic23 (26.4%)10 (12.8%)
 Cystic fibrosis-related bronchiectasis5 (5.7%)6 (7.7%)
 Lower respiratory tract infection1 (1.1%)6 (7.7%)
 Iatrogenic3 (3.4%)3 (3.8%)
 Pulmonary embolism1 (1.1%)5 (6.4%)
 Arteriovenous malformation4 (4.6%)1 (1.3%)
 Pulmonary oedema03 (3.8%)
 Others6 (6.9%)3 (3.8%)

ICU: intensive care unit. #: 15 patients initially assigned to non-BAE approach later received BAE. Eight had bronchiectasis (including one CF-related), four had lung cancer, one had iatrogenic haemoptysis, one had arteriovenous malformation and the other case remained idiopathic; : four of those patients had surgery.